| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $151K | — |
| R&D Expense | $135.3M | +55.0% |
| SG&A Expense | $34.8M | +26.6% |
| Operating Income | -$169.9M | -48.0% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$153.0M | -46.2% |
| Income Tax | $0 | — |
| Net Income | -$153.0M | -46.2% |
| EPS (Basic) | -$5.20 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $331.1M | +18.7% |
| Accounts Receivable | $143K | — |
| Current Assets | $347.3M | +21.5% |
| Total Assets | $370.0M | +20.6% |
| Current Liabilities | $24.4M | +47.3% |
| Total Liabilities | $37.8M | +28.8% |
| Stockholders' Equity | $332.2M | +19.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$124.5M | -77.7% |
| Capital Expenditures | $2.5M | +98.5% |
| Investing Cash Flow | -$2.5M | -98.5% |
| Financing Cash Flow | $179.0M | +48.7% |
| Free Cash Flow | -$127.0M | -78.1% |
| -25.3% |
| EPS (Diluted) | -$5.20 | -25.3% |